Ostomy refers to a surgical procedure that allows the passage of bodily wastes through a surgically created stoma or aperture on the abdomen into a prosthetic such as a pouch or bag placed outside the body. Ostomy is performed on patients suffering from various medical conditions, including cancer, birth defects, diverticulitis, incontinence, and inflammatory bowel disease. This procedure is also performed on patients suffering from severe abdominal and pelvic trauma caused due to accidents or severe injuries. Ostomy is also known as continent diversion surgery and can be performed on patients of all age groups. The procedure does not affect life expectancy of an individual.

Ostomy leads to elimination of waste material from the body through stoma, which is part of the intestine that lacks presence of contraction muscles, thus resulting in loss of control of the individual on excretion of gas or solid waste from the body. The waste is automatically collected in a plastic bag or pouch that holds the waste and helps block the smell at the same time. Ostomy leads to rerouting of bodily waste from its usual path that can result due to malfunctioning parts of the digestive or urinary system. Depending on the severity of the patient, the ostomy can be temporary or permanent. The most common types of ostomies involve colostomy, ileostomy, urostomy, J-pouch, and continent urostomy among others.

Request for Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1687

Market Dynamics

The rising number of ostomy procedures being performed is the primary factor responsible for driving growth of the global ostomy care market. For instance, according to National Center for Biotechnology Information, around 100,000 people underwent operations resulting in colostomy or ileostomy in the U.S., in 2014. Increasing prevalence of inflammatory bowel disease is also expected to increase the demand for ostomy care. For instance, according to a research survey published in ‘The Lancet’ in October 2017, western countries suffer with a high prevalence of inflammatory bowel disease that has surpassed 0.3% of the total population. Moreover, according to the Worldwide Incidence and Prevalence of Inflammatory Bowel Disease (IBD) in the 21st Century: A Systematic Review of Population-Based Studies 2017, the incidence of IBD and Crohn’s disease is increasing in Latin America, Africa, and Asia Pacific. Various other factors responsible for the growth of market include rising incidence of bladder cancer, birth defects, and technological advancements. For instance, around 10,171 cases of bladder cancer were reported in the U.K. in 2015, out of which 50% cases survived through proper medication and care. However, low awareness in underdeveloped and developing economies regarding the availability of treatments and increasing pricing pressure on the manufacturer is expected to confine the market growth.

Regional Insights

On the basis of region, the global ostomy care market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global ostomy care market and is expected to retain its dominance over the forecast period, owing to large population suffering from Crohn’s disease, inflammatory bowel diseases, and other diseases in the region. According to the Centers of Disease Control and Prevention, around 1.3% of the adults in the U.S., accounting up to 3 million patients were reported to be suffering from inflammatory bowel disease in 2015 that increased the overall hospitalization rate in the country.

Furthermore, Asia Pacific is expected to witness a significant growth in the market, which is attributed to increasing efforts undertaken by government and non-government organization to support research, generate awareness, and increase the availability of treatment options to patients in their native countries. For instance, the Japan Ostomy Education is a non-profit organization approved by Ministry of Health, Labor and Welfare in Japan that conducts various activities concerned with stoma care for delivering a better life to patients suffering from related medical issues in Japan.

Request fot TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1687

Competitive Insights

Key players operating in the global ostomy care market include 3M Company, Coloplast Corporation, ConvaTec, Inc, Hollister, Inc., Smith & Nephew Plc, Alcare, Nu-Hope, Welland Medical, Cymed, and Flexicare Medical. Market players are focused on providing technologically advanced products, to sustain their position in the competitive market. For instance, in March 2015, Welland Medical introduced Aurum 2, a range of 2-piece ostomy pouches that is inclusive of flange with added medical grade Manuka honey.

Market Taxonomy

On the basis of product type, the global ostomy care market is segmented into:

Bags

Colostomy Bags

Ileostomy Bags

Urostomy Bags

Others

Pouches

Accessories

Convex Inserts

Plastic Sheets

Ostomy Belts

Pouch Covers

Skin Barriers

Liquids

Wipes

Powders

Pastes

Tapes

Adhesive Removers

On the basis of end user, the global ostomy care market is segmented into:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

 On the basis of region, the global ostomy care market is segmented into:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]